Patented biomarker for cardiac injury. 

UK Researchers Eye Alternative POC Test to Troponin to Quickly Rule Out Heart Attack

King’s College London researchers are developing a point-of-care blood test to diagnose heart attacks that uses cardiac myosin-binding protein C as an alternative biomarker to high-sensitivity troponin used in laboratory testing.
In patients that present with myocardial injury, cMyC protein is “much more abundant than cardiac troponin,” Tom Kaier, one of the lead researchers at King’s College London, said in an interview. “We’re seeing up to 10 times more cMyC than troponin, and with more molecules of the marker in the bloodstream, it is substantially easier to detect.”
360 Dx
360 Dx